Eris Lifesciences (NSE:ERIS) Price Target Increased by 13.89% to 917.69
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
The average one-year price target for Eris Lifesciences (NSE:ERIS) has been revised to 917.69 / share. This is an increase of 13.89% from the prior estimate of 805.80 dated August 1, 2023. The price target is an average of many targets provided by analysts. Th
:max_bytes(150000):strip_icc():format(jpeg)/paperwork-4596472be17e44b691fc63ab4caa74a4.jpg "<div>Taxable Income vs. Gross Income: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1438233969-08b4f322bd6f4c04b75978968d305bd5.jpg "How Is Your 401(k) Taxed in Retirement?")